Preventive treatment of migraine: An overview

Cephalalgia

Volumn 17, Issue 2, 1997, Pages 67-72

  Silberstein, S D ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Migraine; Preventive; Prophylactic; Treatment

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CYPROHEPTADINE; DIHYDROERGOTAMINE; ERGOTAMINE; LITHIUM; METHYSERGIDE; MONOAMINE OXIDASE INHIBITOR; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PHENYTOIN; SEROTONIN 1 AGONIST; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VERAPAMIL;

ANALGESIA; CLINICAL TRIAL; COMORBIDITY; HUMAN; MIGRAINE; NEUROPHARMACOLOGY; ORAL DRUG ADMINISTRATION; PROPHYLAXIS; SHORT SURVEY;

HUMANS; MIGRAINE DISORDERS;

EID: 0030989794     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1997.1702067.x     Document Type: Short Survey

References (30)

1. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine in the United States. JAMA 1992;267:64-9
2. Lipton RB, Stewart WF. Migraine in the United States: epidemiology and healthcare utilization. Neurology 1993;43(3):6-10
3. Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology 1994;44(7):6-16
4. Lipton RB, Silberstein SD. Why study the comorbidity of migraine? Neurology 1994;44(17):4-5
5. Silberstein SD, Saper J. Migraine: diagnosis and treatment. In: Dalessio D, Silberstein SD, editors. Wolff's headache and other head pain (6th ed). New York: Oxford University Press, 1993:96-170
6. Silberstein SD. Review: serotonin (5HT) and migraine. Headache 1994;34:408-17
7. Brewerton TD, Murphy DL, Mueller EA, Jimerson DC. Induction of migraine-like headaches by the serotonin agonist m-chlorophenylpiperazine. Clin Pharmacol Ther 1988;43:605-9
8. Gordon ML, Lipton RB, Brown SL, et al. Headache and cortical responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia 1993;13:400-5
9. Humphrey PPA, Feniuk W, Perren MJ. Anti-migraine drugs in development: advances in serotonin receptor pharmacology. Headache 1990;30(1):12
10. Peroutka SJ. Developments in 5-hydroxytryptamine receptor pharmacology in migraine. Neurol Clin 1990;8:829-38
11. Moskowitz MA. Basic mechanisms in vascular headache. Neurol Clin 1990;8:801-15
12. Peroutka SJ. The pharmacology of current antimigraine drugs. Headache 1990;30(1):12
13. Saxena PR. Cranial arteriovenous shunting: an in vivo animal model for migraine. In: Olesen J, Moskowitz MA, editors. Experimental headache models. Philadelphia: Lippincott-Raven, 1995:189
14. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992A;13:307-11
15. Dryden S, Wang Q, Frankish HM, Pickavance L, Williams G. Brain Res 1995;699:12-8
16. 2+ channel gene CACNL1A4. Cell 1996;87:543-52
17. Schoenen J, DeNoordhout AM, Berthier MT, Timsit M. Contingent negative variation and efficacy of beta-blocking agents in migraine. Cephalalgia 1986;6:231-3
18. Curran DA, Hinterberger H, Lance JW. Methysergide: research clinical studies. Headache 1967;1:74-122
19. Silberstein SD, Willmore LJ. Divalproex sodium: migraine treatment and monitoring. Headache 1996;36:239-42
20. Silberstein SD. Migraine and pregnancy. Neurol Clin 1996 (in press)
21. Tfelt-Hansen P, Welch KMA. Prioritizing prophylactic treatment. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press, 1993:403-4
22. Silberstein SD. Divalproex sodium in headache - literature review and clinical guidelines. Headache 1996;36:547-55
23. Solomon GD. Management of the headache patient with medical illness. Clin J Pain 1989;5:95-9
24. Silberstein SD, Lipton RB, Breslau N. Migraine: association with personality characteristics and psychopathology. Cephalalgia 1995;15:337-69
25. Mathew NT, Saper JR, Silberstein SD, Tolander LR, Markley H, Solomon S, et al. Prophylaxis of migraine headaches with divalproex sodium. Arch Neurol. 1995;52:281-6
26. Hering R, Kuritzky A. Sodium valproate has a prophylactic effect in migraine: a double-blind study vs placebo. Cephalalgia 1992;12:81-4
27. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918-24
28. Barnhart ER, editor. Physicians' desk reference. 50th ed. Medical Economics Inc, Oradell NJ 1996
29. Saper JR, Silberstein SD, Gordon CD, Hamel RL, editors. Handbook of headache management: a practical guide to diagnosis and treatment of head, neck, and facial pain. Baltimore: Williams and Wilkins 1993
30. Raskin NH. Headache. 2nd ed. New York: Churchill-Livingstone, 1988